Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors. N Engl J Med, 367, 1487-1496. presented at the 10/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23075175. (2012).
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Comparative Effectiveness Analysis of CD34+ Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts on Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Myeloid Leukemia (AML) in Complete Remiss (Poster). In BMT Tandem Meeting. presented at the 2010, Orlando, FL.. (2010).
Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation. Blood, 116, 5111-5118. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20826719. (2010).
Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network. Blood, 114, 511-517. presented at the 07/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19443659. (2009).